Exelixis, Inc. (EXEL)
41.05
-0.82
(-1.96%)
USD |
NASDAQ |
Dec 10, 16:00
41.15
+0.10
(+0.24%)
After-Hours: 19:13
Exelixis Price: 41.05 for Dec. 10, 2025
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Vanda Pharmaceuticals, Inc. | 6.73 |
| ADMA Biologics, Inc. | 19.98 |
| Aldeyra Therapeutics, Inc. | 4.775 |
| Merck & Co., Inc. | 97.58 |
| ACADIA Pharmaceuticals, Inc. | 26.81 |
Price Related Metrics
| PE Ratio | 17.28 |
| PS Ratio | 5.134 |
| PEG Ratio | 0.3364 |
| Price to Book Value | 5.094 |
| Price to Free Cash Flow | 15.06 |
| Earnings Yield | 5.79% |
| Market Cap | 11.01B |
| PEGY Ratio | 0.3364 |
| Operating PE Ratio | 14.32 |
| Normalized PE Ratio | 16.92 |